12935 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2323)
  9. Epidemiology and Biostatistics (1996)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3611)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12935)
  2. GSK Faculty (6209)
  3. Department of Medicine (4655)
  4. Sloan Kettering Institute Faculty (3489)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (393)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12935)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monoclonal gammopathy of undetermined significance (MGUS) with multiple paraproteins: Results from the population-based iStopMM screening study
    Meeting Abstract

    Rögnvaldsson , S.; Oskarsson, J. Þ.; Thorsteinsdottir, S.; Reed, E. R.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Sigurdardottir, M.; Agnarsson, B. A.; Olafsson, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: Results of the prospective population-based iStopMM study
    Meeting Abstract

    Sverrisdottir, I. S.; Thorsteinsdóttir, S.; Rögnvaldsson, S.; Aspelund, T.; Vidarsson, B.; Önundarson, P. T.; Agnarsson, B.; Sigurdardóttir, M.; Thorsteinsdottir, I.; Sveinsdottir, S. V.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Geometric network analysis defines poor-prognosis subtypes in multiple myeloma
    Meeting Abstract

    Simhal, A. K.; Maclachlan, K. H.; Elkin, R.; Zhu, J.; Usmani, S.; Keats, J. J.; Norton, L.; Deasy, J. O.; Oh, J. H.; Tannenbaum, A.
    Blood (2022)

    Fulltext@MSK | Save
  • Circulating tumor plasma cells in the screened iStopMM smoldering multiple myeloma cohort
    Meeting Abstract

    Thorsteinsdóttir, S.; Oskarsson, J. Þ.; Rögnvaldsson, S.; Gíslason, G.; Aspelund, T.; Sigurdardottir, G. Á; Thordardottir, Á. R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Incidence, clinical associations, and co-mutation patterns of UBA1 mutations in MDS
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Beck, D. B.; Creignou, M.; Domenico, D.; Farina, A.; Arango, J. E.; Kosmider, O.; Hasserjian, R. P.; Jadersten, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • BCL6-mediated escape from negative selection enables RAS-driven B-cell transformation
    Meeting Abstract

    Chan, L. N.; Hurtz, C.; Robinson, M. E.; Leveille, E.; Geng, H.; Caeser, R.; Xu, L.; Kume, K.; Xiao, G.; Müschen, M.
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • A phase II clinical trial of E7820 for patients with relapsed/refractory myeloid malignancies with mutations in splicing factor genes
    Meeting Abstract

    Bewersdorf, J. P.; Stahl, M. F.; Taylor, J.; Chandhok, N. S.; Watts, J.; Derkach, A.; Wysocki, M.; Kostantakis, V.; Lu, S. X.; Bourcier, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Cohesin dependency in NPM1(c/+) and FLT3-ITD mutant hematopoietic stem and progenitor cells
    Meeting Abstract

    Xu, J. J.; Alija, B.; Braunstein, S.; Pantazi, J.; Sudunagunta, V. S.; Bowman, R. L.; Viny, A. D.
    Blood (2022)

    Fulltext@MSK | Save